Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 10/20 | 0.45 |
| ▸ | CA9 | Q16790 | 10/20 | 0.45 |
| ▸ | CA2 | P00918 | 9/20 | 0.45 |
| ▸ | CA7 | P43166 | 7/20 | 0.45 |
| ▸ | CA1 | P00915 | 6/20 | 0.45 |
| ▸ | CA4 | P22748 | 2/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | USP2 | O75604 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | BCHE | P06276 | 1/20 | 0.45 |
| ▸ | CA6 | P23280 | 1/20 | 0.45 |
| ▸ | CA5A | P35218 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.45 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | AKT1 | P31749 | 1/20 | 0.33 |
| ▸ | LIG1 | P18858 | 1/20 | 0.33 |
| ▸ | PDE7A | Q13946 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1081860 | 0.81 | CA12 (0.50) | CA12CA9CA2CA7CA1 | |
| SCHEMBL10656700 | 0.80 | CA12 (0.49) | CA12CA9CA2CA7CA1 | |
| SCHEMBL10741433 | 0.78 | TYMS (0.43) | CA12CA9CA2CA7CA1 | |
| SCHEMBL8995896 | 0.78 | CA12 (0.44) | CA12CA9CA2CA7CA1 | |
| SCHEMBL362202 | 0.77 | CYP3A4 (0.51) | KDM4ELMNABCHEKMT2ACYP2D6 | |
| SCHEMBL19586659 | 0.75 | CA12 (0.43) | CA12CA9CA2CA7CA1 | |
| SCHEMBL7763714 | 0.75 | CA12 (0.44) | CA12CA9CA2CA7CA1 | |
| SCHEMBL1661224 | 0.74 | CA12 (0.46) | CA12CA9CA2CA7CA1 | |
| SCHEMBL10734721 | 0.74 | CA12 (0.42) | CA12CA9CA2CA7CA1 | |
| SCHEMBL6739070 | 0.72 | CA12 (0.41) | CA12CA9CA2CA7CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1649037-A4 | IMMOBILIZATION OF OLIGONUCLEOTIDES AND PROTEINS IN SUGAR-CONTAINING HYDROGELS | US GOV SEC NAVY (US) | 2008-04-23 | — | — | EP | claimed |
| US-20060246499-A1 | Sugar-containing hydrogel for immobilization | NAVY, U.S.A. AS REPRESENTED BY THE SECRETARY OF THE, THE | 2006-11-02 | — | — | US | claimed |
| EP-1649037-A2 | IMMOBILIZATION OF OLIGONUCLEOTIDES AND PROTEINS IN SUGAR-CONTAINING HYDROGELS | The Government of the United States of America as represented by the Secretary of the Navy (US) | 2006-04-26 | — | — | EP | claimed |
| WO-2005017180-A2 | IMMOBILIZATION OF OLIGONUCLEOTIDES AND PROTEINS IN SUGAR-CONTAINING HYDROGELS | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2005-02-24 | — | — | WO | claimed |
| US-20050019884-A1 | Immobilization of oligonucleotides and proteins in sugar-containing hydrogels | NAVY, THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE | 2005-01-27 | — | — | US | claimed |
| EP-0237131-B1 | PROCESS FOR THE PREPARATION OF WATER-SOLUBLE SACCHARIDE POLYMERS | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1991-07-24 | — | — | EP | claimed |
| US-4701494-A | USING (METH) ACRYLOYL MONO- AND DISACCHARIDES, AN AZO FREE RADICAL CATALYST AND LIMITED AMOUNT OF MONOMER IN AQUEOUS SOLUTION | SHELL OIL COMPANY (US) | 1987-10-20 | — | — | US | claimed |
| US-5480790-A | PROTEINS ARE COVALENTLY BOUND TO POLYVINYLSACCHARIDE VIA A SACCHARIDE RESIDUE; PROTEIN-SACCHARIDE COMPLEXES SUCH AS DEXTRAN-T-40-ALPHA-GLUCOSIDASE AND GLUTAMATE DEHYDROGENASE POLYVINYLSACCHARIDE; ENZYME ANALYSIS; TEST KIT | BOEHRINGER MANNHEIM GMBH (DE) | 1996-01-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050019884-A1 | Immobilization of oligonucleotides and proteins in sugar-containing hydrogels | PHAX, SLC2A4, CD44 | CA12 1202/4885CA9 1613/4885CA2 1638/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.